Risk assessment of left ventricular systolic dysfunction in primary care. Drug treatment might be contaminating factor
- PMID: 10950527
- PMCID: PMC1127728
Risk assessment of left ventricular systolic dysfunction in primary care. Drug treatment might be contaminating factor
Comment on
-
Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests.BMJ. 2000 Jan 22;320(7229):220-4. doi: 10.1136/bmj.320.7229.220. BMJ. 2000. PMID: 10642232 Free PMC article. Clinical Trial.
References
-
- Murdoch DR, McDonagh TA, Byrne J, Blue L, Farmer R, Morton JJ, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration. Am Heart J. 1999;138:1126–1132. - PubMed
-
- Northridge DB, Newby DE, Rooney E, Norrie J, Dargie HJ. Comparison of the short-term effects of candoxatril, an orally active neutral endopeptidase inhibitor, and frusemide in the treatment of patients with chronic heart failure. Am Heart J. 1999;138:1149–1157. - PubMed
-
- RESOLVD Investigators. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy. Circulation. 2000;101:378–384. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources